Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?
Matrisciano
F
F
Panaccione
I
I
Zusso
M
M
Giusti
P
P
Tatarelli
R
R
Iacovelli
L
L
Mathé
A A
AA
Gruber
S H M
SH
Nicoletti
F
F
Girardi
P
P
D000277:Adjuvants, Pharmaceutic / Q000008:administration & dosage*; D000596:Amino Acids / Q000008:administration & dosage; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000008:administration & dosage; D003866:Depressive Disorder / Q000188:drug therapy; D004195:Disease Models, Animal; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D018683:Excitatory Amino Acid Agents / Q000008:administration & dosage*; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D007099:Imipramine / Q000008:administration & dosage*; D066298:In Vitro Techniques; D051379:Mice; D009474:Neurons / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D020239:Receptor Cross-Talk / Q000187:drug effects; D018094:Receptors, Metabotropic Glutamate / Q000187:drug effects* / Q000378:metabolism; D013997:Time Factors; D014966:Xanthenes / Q000008:administration & dosage
D000277:Adjuvants, Pharmaceutic; D000596:Amino Acids; D000929:Antidepressive Agents, Tricyclic; D019086:Bridged Bicyclo Compounds, Heterocyclic; D018683:Excitatory Amino Acid Agents; C114624:LY 341495; C118218:LY 379268; D018094:Receptors, Metabotropic Glutamate; D014966:Xanthenes; C108822:metabotropic glutamate receptor 2; C102718:metabotropic glutamate receptor 3; D007099:Imipramine